These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3228023)

  • 1. [Serum secretory IgA level in patients with Behçet's disease].
    Nio T; Sunakawa M; Ohshio G; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1988 Nov; 92(11):1740-3. PubMed ID: 3228023
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum secretory IgA levels in patients with Behçet disease.
    Sunakawa M; Ohshio G
    Metab Pediatr Syst Ophthalmol (1985); 1989; 12(4):110-2. PubMed ID: 2628704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory component deficiency in Behçet's disease.
    Hamza M; Makni S
    Clin Rheumatol; 1995 Mar; 14(2):227-8. PubMed ID: 7789068
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease.
    Mantaş C; Direskeneli H; Ekşioglu-Demiralp E; Akoglu T
    J Rheumatol; 1999 Feb; 26(2):510-2. PubMed ID: 9972999
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease.
    Abdou NI; Schumacher HR; Colman RW; Sagawa A; Hebert J; Pascual E; Carroll ET; Miller M; South MA; Abdou NL
    J Lab Clin Med; 1978 Mar; 91(3):409-22. PubMed ID: 627747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antibody titer to streptococcal and staphylococcal L-form in Behçet's disease].
    Ogawa T; Namba K; Nishiyama Y; Sawada K
    Nippon Ganka Gakkai Zasshi; 1990 Apr; 94(4):408-12. PubMed ID: 2396591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neopterin levels in Behçet's syndrome.
    Keser G; Oksel F; Aksu K; Kabasakal Y; Gümüşdiş G; Doganavş argil E; Sin A
    Clin Rheumatol; 2000; 19(4):328-9. PubMed ID: 10941821
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetanus antitoxin seroprevalence in patients with Behçet's disease.
    Ayaslioglu E; Erkek E; Kiliç D; Kaygusuz S; Karaca F; Düzgün N
    Scand J Infect Dis; 2003; 35(5):299-301. PubMed ID: 12875513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of antiendothelial cell antibodies in Behcet's disease].
    Zheng WJ; Zhao Y; Tang FL; Dong Y
    Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relation between Behçet's disease and interleukin-1 beta production].
    Katayama T; Tachinami K; Ishiguro M; Kubota Y
    Nippon Ganka Gakkai Zasshi; 1994 Feb; 98(2):197-201. PubMed ID: 8109465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased solubilization of immune complexes by the sera from patients with Behcet's disease.
    Tanaka K; Kajiyama K; Kameda S; Nishigouri S; Yamada I; Sawae Y
    Tohoku J Exp Med; 1983 Aug; 140(4):363-8. PubMed ID: 6636135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of serum transforming growth factor-beta1 do not increase in Behçet's disease, in contrast to rheumatoid arthritis.
    Eksioglu-Demiralp E; Direskeneli H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):1010-1. PubMed ID: 10229441
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
    Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
    Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
    Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
    Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.